trending Market Intelligence /marketintelligence/en/news-insights/trending/stio__y67ig5q8x5pmt57g2 content esgSubNav
In This List

Aurinia Pharmaceuticals appoints director

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Aurinia Pharmaceuticals appoints director

Canada's Aurinia Pharmaceuticals Inc. added Michael Hayden to its board.

Hayden most recently served as president of global research and development and chief scientific officer at Teva Pharmaceutical Industries Ltd.